Cambiar Investors LLC decreased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 9.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 309,210 shares of the medical instruments supplier's stock after selling 31,024 shares during the period. Cambiar Investors LLC owned 0.16% of DENTSPLY SIRONA worth $5,869,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. FMR LLC increased its position in shares of DENTSPLY SIRONA by 5.1% in the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier's stock worth $245,076,000 after acquiring an additional 436,031 shares in the last quarter. Pacer Advisors Inc. increased its position in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after acquiring an additional 4,473,972 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of DENTSPLY SIRONA by 50.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier's stock worth $55,900,000 after acquiring an additional 692,100 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. Finally, National Bank of Canada FI increased its position in shares of DENTSPLY SIRONA by 85.8% in the third quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier's stock worth $44,059,000 after acquiring an additional 751,800 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.
DENTSPLY SIRONA Stock Performance
Shares of NASDAQ XRAY traded down $0.45 during midday trading on Friday, hitting $18.32. The company's stock had a trading volume of 2,580,852 shares, compared to its average volume of 2,345,229. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $34.91. The firm's fifty day moving average price is $19.02 and its 200-day moving average price is $21.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a market cap of $3.64 billion, a P/E ratio of -8.85, a P/E/G ratio of 1.83 and a beta of 0.96.
DENTSPLY SIRONA Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA's payout ratio is -30.92%.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on the stock. StockNews.com raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, February 7th. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research note on Tuesday, December 3rd. Mizuho began coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 target price for the company. Needham & Company LLC reiterated a "buy" rating and set a $25.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday. Finally, Leerink Partners lowered shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Ten equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and a consensus target price of $25.85.
Get Our Latest Research Report on XRAY
DENTSPLY SIRONA Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
